For the quarter ending 2025-09-30, CLMT had -$16,000K decrease in cash & cash equivalents over the period. $15,100K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Adjusted ebitda | 162,800 | - | - |
| Sales | - | 1,026,600 | 993,900 |
| Depreciation and amortization | 145,300 | - | - |
| Cost of sales | - | 1,070,200 | 1,075,300 |
| Gross profit (loss) | - | -43,600 | -81,400 |
| Selling | - | 12,200 | 12,300 |
| General and administrative | - | 41,100 | 12,100 |
| Lcm / lifo (gain) loss | -3,100 | - | - |
| (gain) loss on sale of business | -6,400 | 0 | 62,200 |
| Other operating expense | - | -4,100 | -5,100 |
| Operating income (loss) | - | -101,000 | -48,700 |
| Interest expense | 53,600 | 52,900 | 58,500 |
| Debt extinguishment costs | 500 | -100 | -47,600 |
| Unrealized Gain Loss On Derivatives | 9,100 | - | - |
| Unrealized gain on derivatives | 9,100 | - | - |
| Rins incurrence gain (expense) | -257,400 | - | - |
| Gain (loss) on derivative instruments | - | 4,300 | -7,200 |
| Other income | - | 2,000 | 400 |
| Rins mark-to-market loss (gain) | 145,100 | - | - |
| Total other expense | - | -46,700 | -112,900 |
| Other non-recurring expenses (income) | 2,100 | - | - |
| Net loss before income taxes | - | -147,700 | -161,600 |
| Equity-based compensation and other items | 6,100 | - | - |
| Income tax (benefit) expense | -41,400 | 200 | 400 |
| Noncontrolling interest adjustments | -8,500 | - | - |
| Net income (loss) | 313,400 | -147,900 | -162,000 |
| Non-cash rins gain | -324,000 | 94,400 | 117,200 |
| Unrealized (gain) loss on derivative instruments | 2,000 | 1,700 | 5,400 |
| Other adjustments to reconcile net income (loss) to cash flow from operating activities | -82,000 | -61,900 | -20,600 |
| Changes in assets and liabilities | -45,900 | -8,500 | 300 |
| Net cash used in operating activities | 23,500 | -1,800 | -29,300 |
| Additions to property, plant and equipment | 8,400 | 13,600 | 17,600 |
| Proceeds from sale of business, net | 0 | 0 | 95,400 |
| Net cash provided by (used in) investing activities | -8,400 | -13,600 | 77,800 |
| Proceeds from borrowings - revolving credit facility | 538,700 | 519,500 | 838,200 |
| Repayments of borrowings - revolving credit facility | 579,500 | 364,700 | 1,071,200 |
| Proceeds from borrowings - mrl revolving credit agreement | 0 | 0 | 26,600 |
| Repayments of borrowings - mrl revolving credit agreement | 0 | 0 | 26,700 |
| Proceeds from borrowings - senior notes | 0 | 0 | 100,000 |
| Repayments of borrowings - senior notes | 80,000 | 150,000 | - |
| Proceeds from inventory financing | 90,200 | 86,700 | 88,000 |
| Payments on inventory financing | 74,900 | 84,500 | 147,000 |
| Proceeds from doe loan | 0 | 0 | 781,800 |
| Proceeds from other financing obligations | 120,000 | 0 | 40,000 |
| Repayments of borrowings - mrl asset financing arrangements | 0 | 0 | 396,100 |
| Repayments of borrowings - mrl term loan credit agreement | 0 | 0 | 86,000 |
| Payments on other financing obligations | 45,600 | 4,400 | 38,600 |
| Net cash provided by financing activities | -31,100 | 2,600 | 109,000 |
| Net increase in cash, cash equivalents and restricted cash | -16,000 | -12,800 | 157,500 |
| Cash and cash equivalents at beginning of period | 190,600 | 203,400 | 45,900 |
| Cash and cash equivalents at end of period | 174,600 | 190,600 | 203,400 |
Calumet, Inc. DE (CLMT)
Calumet, Inc. DE (CLMT)